MARKET

SIOX

SIOX

Sio Gene Therapies Inc
NASDAQ
0.3099
-0.0009
-0.29%
Opening 12:43 11/28 EST
OPEN
0.3100
PREV CLOSE
0.3108
HIGH
0.3109
LOW
0.2973
VOLUME
92.80K
TURNOVER
10.20K
52 WEEK HIGH
1.629
52 WEEK LOW
0.2303
MARKET CAP
22.92M
P/E (TTM)
-0.9188
1D
5D
1M
3M
1Y
5Y
Sio Gene Therapies GAAP EPS of -$0.04 beats by $0.15
Seekingalpha · 11/10 13:43
BRIEF-Sio Gene Therapies Announces Second Quarter Financial Results
Reuters · 11/10 13:27
Sio Gene Therapies Q2 EPS $(0.04) Up From $(0.29) YoY
Benzinga · 11/10 12:19
Sio Gene Therapies GAAP EPS of -$0.11 beats by $0.08
Sio Gene Therapies press release (<span class="ticker-hover-wrapp...
Seekingalpha · 08/11 12:47
Recap: Sio Gene Therapies Q4 Earnings
  Sio Gene Therapies (NASDAQ:SIOX) reported its Q4 earnings results on Tuesday, June 14, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Benzinga · 06/14 11:22
Sio Gene Therapies GAAP EPS of -$0.18 misses by $0.01
Sio Gene Therapies press release (NASDAQ:SIOX): Q4 GAAP EPS of -$0.18 misses by $0.01. As of March 31, 2022, the company had $63.7 million of cash and cash equivalents. Shares
Seekingalpha · 06/14 11:18
Sio Gene Therapies Q4 EPS $(0.18) Beats $(0.20) Estimate
Sio Gene Therapies (NASDAQ:SIOX) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.20) by 10 percent. This is a 260 percent decrease over losses of $(0.05) per share from the
Benzinga · 06/14 11:13
Bluebird Bio drives gene therapy stocks higher after FDA review
A group of biotechs focused on gene therapy candidates surged on Tuesday after the FDA posted a favorable review on a β-thalassemia candidate developed by commercial-stage company Bluebird bio (NASDAQ:BLUE)
Seekingalpha · 06/07 19:59
More
About SIOX
Sio Gene Therapies Inc. is a clinical-stage company. The Company is focused on pushing the boundaries of gene therapy to develop treatments for debilitating rare neurodegenerative diseases, including GM1 gangliosidosis and Tay-Sachs/Sandhoff disease. The Company is primarily focused on pre-clinical research and development initiatives in gene therapy.

Webull offers kinds of Sio Gene Therapies Inc stock information, including NASDAQ:SIOX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SIOX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SIOX stock methods without spending real money on the virtual paper trading platform.